Research & Development

Can FasL Inhibition Revolutionize Severe COVID-19 Treatment?
Research & Development Can FasL Inhibition Revolutionize Severe COVID-19 Treatment?

The ongoing battle against COVID-19 has led to numerous scientific breakthroughs, with one of the most promising being the inhibition of FasL (Fas ligand) to treat severe cases. This article delves into the impacts of FasL inhibition on the recovery and mortality of severe COVID-19 patients, based

Pharma's Growing Influence in Cancer Research Raises Critical Questions
Research & Development Pharma's Growing Influence in Cancer Research Raises Critical Questions

In recent years, a noticeable shift has emerged in the realm of clinical cancer research, with pharmaceutical companies now playing a dominant role in funding and conducting trials. This transformation is evident in the stark contrast between industry and federal sponsorships. Between 2018 and

Cordyceps Militaris Fungus Offers Promising New Avenue for Cancer Treatment
Research & Development Cordyceps Militaris Fungus Offers Promising New Avenue for Cancer Treatment

In the world of modern medicine, finding innovative, safer, and more effective treatments for cancer remains a relentless pursuit. Researchers from the University of Nottingham have turned their attention to an unassuming yet potent ally in this fight—the parasitic fungus Cordyceps militaris. S

Advancements and Challenges of AAV Vectors in Gene Therapy Trials
Research & Development Advancements and Challenges of AAV Vectors in Gene Therapy Trials

Gene therapy has emerged as a revolutionary approach to treating genetic disorders by delivering therapeutic genetic material directly into patients' cells. Among the various vectors used for gene delivery, Adeno-Associated Virus (AAV) vectors have gained significant attention due to their

How Is Simoa Revolutionizing Alzheimer’s Diagnosis and Treatment?
Research & Development How Is Simoa Revolutionizing Alzheimer’s Diagnosis and Treatment?

The landscape of Alzheimer’s disease (AD) diagnosis and treatment is undergoing a significant transformation thanks to the groundbreaking Simoa® technology by Quanterix. This ultra-sensitive immunoassay platform is reshaping how biomarkers are identified and validated, offering new possibilities fo

Transforming Cancer Research with Patient-Derived Organoid Innovation
Research & Development Transforming Cancer Research with Patient-Derived Organoid Innovation

Cancer research has entered a new era with the advent of patient-derived organoids (PDOs). These sophisticated three-dimensional (3D) models, grown from patient cells, have revolutionized our understanding of tumors and their microenvironments. By mimicking the complexity of human tumors, PDOs have

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later